Hydrogel Beads for Gradual Cryoprotectant Exchange in Cell Freezing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for cryopreservation of large volumes of cells, such as lymphocytes, are inadequate in preventing osmotic damage during the exchange of cryoprotective agents, leading to low cell viability and unreliable clinical outcomes.
Innovation Solution
The use of hydrogel beads that act as molecular sponges to gradually release and absorb cryoprotective agents, allowing for controlled and distributed loading and unloading of these agents during cryopreservation, thereby protecting cells from osmotic damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional media exchange methods are used to load and unload cryoprotective agents, then the process can be performed with simple equipment and procedures, but the cells suffer from osmotic damage leading to low viability
Solution Approach 1:
Hydrogel beads serve as intermediary carriers that mediate the transfer of cryoprotective agents between storage medium and cell suspension. The beads gradually release or absorb CPAs through diffusion, enabling controlled CPA exchange without direct contact between high-concentration CPA and cells, thereby preventing osmotic damage while maintaining simple操作流程
Solution Approach 2:
The hydrogel beads possess porous structures that allow controlled diffusion of cryoprotective agents. The porous network enables gradual CPA release or absorption rates, preventing sudden concentration changes that would cause osmotic shock to cells, while maintaining the simplicity of the media exchange process
2Reliability
If gradual dropwise addition of concentrated CPAs is used to reduce hypertonic shock, then osmotic damage is reduced, but the method cannot be easily scaled to clinical applications requiring larger sample volumes
Solution Approach 1:
The CPA delivery system is segmented into multiple independent hydrogel beads dispersed throughout the cell suspension. Each bead acts as an independent CPA reservoir, and the collective effect of many beads provides scalable CPA exchange capacity. The number and concentration of beads can be adjusted to match any clinical volume requirement while maintaining the same protective mechanism
Solution Approach 2:
Hydrogel beads serve as scalable intermediary carriers that can be added in quantities proportional to sample volume. For clinical-scale applications, simply increase the amount of beads added to the suspension, maintaining the same gradual CPA exchange mechanism without requiring more complex equipment or procedures
3Reliability
If high volume fractions of miscible solvents like DMSO or glycerol are used in cryopreservation medium, then intracellular ice formation is prevented, but excessive hypertonic and hypotonic shock occurs during washing
Solution Approach 1:
Hydrogel beads are pre-loaded with high concentrations of cryoprotective agents before being added to cell suspensions. This preliminary preparation allows the beads to gradually release CPAs into the medium during the freezing process, ensuring adequate CPA concentration is present to prevent intracellular ice formation without requiring direct addition of high-concentration CPA that would cause osmotic shock
Solution Approach 2:
The hydrogel beads act as intermediary reservoirs that decouple the need for high CPA concentrations from direct cell exposure. The beads maintain high CPA concentrations within their matrix while releasing them gradually into the surrounding medium, preventing both intracellular ice formation and osmotic shock to cells
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the viability of cryopreserved cells, achieving greater than 50% viability, addressing the limitations of conventional methods and enabling reliable cryopreservation for clinical applications.
Implementation Method 1
hydrogel beads can act as molecular 'sponges' that release and/or absorb cryoprotective agents from a suspension of cells
Implementation Method 2
hydrogel beads can act as molecular 'sponges' that release and/or absorb cryoprotective agents from a suspension of cells, e.g., animal cells, such as white blood cells, e.g., lymphocytes, in a gradual and distributed manner that protects the cells from osmotic damage
Data Source
AI summary
Hydrogel beads having tunable rates of loading and unloading of cryoprotective agents are provided herein. Such hydrogel beads can be dispersed throughout a cell suspension to enable loading and unloading of cryoprotective agents from cells in a gradual and distributed manner that protects the cells from osmotic damage. Lymphocyte viability after cryopreservation is significantly greater when cryoprotective agents are loaded and unloaded using hydrogel beads compared to conventional media exchange methods.